Cell Therapeutics (CTIC) Sees Momentum Run-Up
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Join SI Premium – FREE
Momentum traders are all over Cell Therapeutics, Inc. (NASDAQ: CTIC) Tuesday following Peregrine Pharmaceuticals' (NASDAQ: PPHM) 80% surge yesterday.
Shares of CTIC last traded at up 25% to $1.63. Volume is already more than 3x the full day norm.
Shares of CTIC last traded at up 25% to $1.63. Volume is already more than 3x the full day norm.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley lists top 10 AI stocks to buy in Europe
- 2 cyberstocks to buy on resilient cyber demand: analyst
- Top CPU stocks to buy as analysts say "renaissance thesis is playing out"
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
